Volume 7, Number 2—April 2001
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections
State of the Art
Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs
|Plasmid analysis||Staphylococci Enterobacteriaceae||Plasmids may be digested with restriction endonucleases Only useful when organisms carry plasmids|
|Restriction endonuclease analysis of chromosomal DNA with conventional electrophoresis||Enterococci Staphylococcus aureus Clostridium difficile Candida spp.||Large number of bands Difficult to interpret Not amenable to computer analysis|
|PFGE||Enterobacteriaceae Staphylococci Enterococci Candida spp.||Fewer bands Amenable to computer analysis Very broad application.|
|Genome restriction fragment length polymorphism analysis: ribotyping, insertion sequence probe fingerprinting||Enterobacteriaceae Staphylococci Pseudomonas aeruginosa Mycobacterium tuberculosis Candida spp.||Fewer bands Computer analysis Sequence-based profiles Automated|
|PCR-based methods: repetitive elements PCR spacer typing, selective amplification of genome restriction fragments, multilocus allelic sequence-based typing||Enterobacteriaceae Acinetobacter spp. Staphylococci M. tuberculosis HCV||Crude extracts and small amounts of DNA may suffice|
|Library probe genotypic hybridization schemes: multilocus probe dot-blot patterns, high-density oligonucleotide patterns||Burkholderia cepacia S. aureus M. tuberculosis||Unambiguous yes-no result Less discrimination than other methods Couple with DNA chip technology|
aThe table contains examples of available methods and applications and is not intended to be all-inclusive.
bAdapted from Pfaller (2).
- Cormican MG, Pfaller MA. Molecular pathology of infectious diseases. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: W.B. Saunders Company; 1996:1390-9.
- Pfaller MA. Diagnosis and management of infectious diseases: Molecular methods for the new millennium. Clinical Laboratory News. 2000;26:10–3.
- Kant JA. Molecular diagnostics: Reimbursement and other selected financial issues. Diagn Mol Pathol. 1995;4:79–81.
- Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: A reconsideration of Koch's postulates. Clin Microbiol Rev. 1996;9:18–33.
- Fredricks DN, Relman DA. Application of polymerase chain reaction to the diagnosis of infectious disease. Clin Infect Dis. 1999;29:475–88.
- Tang YW, Persing DH. Molecular detection and identification of microorganisms. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington: American Society for Microbiology; 1999:215-44.
- Woods GL. Molecular techniques in mycobacterial detection. Arch Pathol Lab Med. 2001;125:122–6.
- Bergeron MG, Ouellette M. Preventing antibiotic resistance using rapid DNA-based diagnostic tests. Infect Control Hosp Epidemiol. 1998;19:560–4.
- Cockerill FR III. Genetic methods for assessing antimicrobial resistance. Antimicrob Agents Chemother. 1999;43:199–212.
- Hacek DM, Suriano T, Noskin GA, Kruszynski J, Reisberg B, Peterson LR. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am J Clin Pathol. 1999;111:647–54.
- Ross JS. Financial determinants of outcomes in molecular testing. Arch Pathol Lab Med. 1999;123:1071–5.
- Pfaller MA. Molecular epidemiology in the care of patients. Arch Pathol Lab Med. 1999;123:1007–10.
- Nolte FS. Impact of viral load testing on patient care. Arch Pathol Lab Med. 1999;123:1011–4.
- Anthony RM, Brown TJ, French GL. Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array. J Clin Microbiol. 2000;38:781–8.
- Marshall SA, Wilke WW, Pfaller MA, Jones RN. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mec A) characterization of oxacillin resistance in the SCOPE Program. Diagn Microbiol Infect Dis. 1998;30:205–14.
- Hussain Z, Stoakes L, Massey V, Diagre D, Fitzgerald V, El Sayed S, Correlation of oxacillin MIC with mec A gene carriage in coagulase-negative staphylococci. J Clin Microbiol. 2000;38:752–4.
- Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998;339:307–11.
- Stuyver L, Van Geyt C, de Gendt S, Van Reybroeck G, Zoulin F, Leroux-Rods G, Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol. 2000;38:702–7.
- Courvalin P. Genotypic approach to the study of bacterial resistance to antibiotics. Antimicrob Agents Chemother. 1991;35:1019–23.
- Arbeit RD. Laboratory procedures for epidemiologic analysis of microorganisms. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington: American Society for Microbiology; 1999:116-37.
- Pfaller MA, Herwaldt LA. The clinical microbiology laboratory and infection control: Emerging pathogens, antimicrobial resistance, and new technology. Clin Infect Dis. 1997;25:858–70.
- Ferreira-Gonzalez A, Garrett CG. Pitfalls in establishing a molecular diagnostic laboratory. Hum Pathol. 1996;27:437–40.
- Back NA, Linnemann CC, Pfaller MA, Staneck JL, Morthland V. Recurrent epidemics caused by a single strain of erythromycin-resistant Staphylococcus aureus: The importance of molecular epidemiology. JAMA. 1993;270:1329–33.
Page created: May 10, 2011
Page updated: May 10, 2011
Page reviewed: May 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.